Fosun International LTD Coherus Bio Sciences, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$16.3 - $23.37 $3.88 Million - $5.57 Million	-238,248 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.1 - $22.1 $602,600 - $1.02 Million	46,000 Added 23.93%	238,248 $5.12 Million
Q1 2019 May 10, 2019	BUY	$8.38 - $15.5 $1.06 Million - $1.96 Million	126,748 Added 193.51%	192,248 $2.64 Million
Q4 2018 Jan 31, 2019	BUY	$8.65 - $16.28 $566,575 - $1.07 Million	65,500 New	65,500 $576,000

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.